| WB | 1/500-1/1000 | Human,Rat,Hamster |
| IF | 咨询技术 | Human,Rat,Hamster |
| IHC | 咨询技术 | Human,Rat,Hamster |
| ICC | 技术咨询 | Human,Rat,Hamster |
| FCM | 咨询技术 | Human,Rat,Hamster |
| Elisa | 咨询技术 | Human,Rat,Hamster |
| Aliases | Integrin beta-5 |
| Entrez GeneID | 3693 |
| WB Predicted band size | Calculated MW: 88 kDa; Observed MW: 88 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Rat,Hamster |
| Immunogen | Recombinant protein of human Integrin beta 5 |
| Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是3篇关于Integrin beta 5抗体的代表性文献(信息基于公开研究整理)：
1. **文献名称**: *"Integrin β5 regulates tumor invasion and metastasis in pancreatic cancer"*
**作者**: Cui et al. (2020)
**摘要**: 该研究利用Integrin β5特异性抗体，发现其在胰腺癌细胞中通过激活TGF-β信号通路促进上皮-间质转化(EMT)，从而增强肿瘤侵袭和转移能力。
2. **文献名称**: *"Targeting integrin β5 for the treatment of choroidal neovascularization"*
**作者**: Smith et al. (2018)
**摘要**: 通过阻断性Integrin β5抗体抑制实验，证明其在脉络膜新生血管形成中调控VEGF信号，为老年性黄斑变性(AMD)提供了潜在治疗靶点。
3. **文献名称**: *"Integrin β5 mediates cellular uptake of exosomes in cancer progression"*
**作者**: Zhao & Li (2021)
**摘要**: 使用Integrin β5抗体阻断功能实验，揭示其在肿瘤外泌体摄取中的关键作用，影响肿瘤微环境中的细胞间通讯和耐药性。
4. **文献名称**: *"A novel monoclonal antibody against integrin β5 modulates angiogenesis"*
**作者**: Park et al. (2019)
**摘要**: 开发了一种高特异性Integrin β5单克隆抗体，验证其通过抑制FAK/PI3K通路显著减少血管内皮细胞迁移和管状结构形成。
(注：以上为模拟文献示例，实际引用请通过PubMed/Google Scholar检索具体文章。)
Integrin beta 5 (ITGB5) is a subunit of the αvβ5 heterodimeric transmembrane receptor, part of the integrin family that mediates cell-extracellular matrix (ECM) and cell-cell interactions. Integrins play critical roles in cell adhesion, migration, signaling, and tissue homeostasis by transmitting bidirectional signals across the plasma membrane. The β5 subunit pairs exclusively with the αv subunit to form the αvβ5 integrin, which recognizes ligands containing the Arg-Gly-Asp (RGD) motif, such as vitronectin, fibronectin, and osteopontin. This receptor is implicated in diverse physiological processes, including angiogenesis, wound healing, and TGF-β activation, as well as pathological conditions like cancer progression, fibrosis, and inflammatory diseases.
Antibodies targeting integrin beta 5 are essential tools for studying its expression, localization, and function. They are widely used in techniques like immunohistochemistry (IHC), flow cytometry, and Western blotting to investigate β5's role in cellular behaviors such as mechanotransduction, apoptosis resistance, and epithelial-mesenchymal transition (EMT). In cancer research, β5 antibodies help assess its overexpression in tumors, which is often linked to metastatic potential and therapeutic resistance. Additionally, these antibodies are explored in preclinical studies to evaluate β5 as a therapeutic target, particularly in anti-angiogenic therapies or targeted drug delivery systems.
Commercial integrin beta 5 antibodies are typically validated for specificity using knockout cell lines or siRNA-mediated knockdown. Researchers must select antibodies based on applications, species reactivity, and epitope regions (e.g., cytoplasmic vs. extracellular domains). Reliable β5 antibodies are crucial for elucidating its crosstalk with signaling pathways (e.g., FAK, PI3K/AKT) and its context-dependent roles in health and disease.
×
